Furthermore, immunohistochemistry (IHC) performed on the proband's tumor tissues showed strong expression of MSH2 (+) and MSH6 (+) but weak expression for MLH1 (-) and PMS2 (-) (Figure 5). The gene discussed is MSH6; the disease is neoplasm.